- Title Pages
- Title Pages
- Acknowledgments
- Introduction
- Harnessing Stem Cells for Regenerative Medicine
-
Dialogue 1 Hope -
Dialogue 2 Why is this Cell Different from Other Cells? -
Dialogue 3 The President’s Stem Cells -
Dialogue 4 The Dickey-Wicker Enigma -
Dialogue 5 The Moral Status of Embryos -
Dialogue 6 Creating Good from Immoral Acts -
Dialogue 7 Circumventing Embryocide -
Dialogue 8 My Personalized Beta Cells for Diabetes -
Dialogue 9 Repairing Brain Cells in Stroke Victims -
Dialogue 10 Reversing Macular Degeneration -
Dialogue 11 My Stem Cells, My Cancer -
Dialogue 12 Reprogramming Cells -
Dialogue 13 My Personalized Disease Cells -
Dialogue 14 To Clone or not to Clone -
Dialogue 15 Patenting Human Embryonic Stem Cells is Immoral and Illegal (In Europe) -
Dialogue 16 My Embryo is Auctioned on the Internet -
Dialogue 17 Here Comes the Egg Man -
Dialogue 18 Human-Animal Chimeras and Hybrids -
Dialogue 19 Stem Cell Tourism -
Dialogue 20 Social Media Meet Science Hype -
Dialogue 21 Feminism and the Commercialization of Human Eggs/Embryos -
Dialogue 22 Was My Birth Embryo Me? -
Dialogue 23 Embryos without Ovaries -
Dialogue 24 How My Cells Became Drugs -
Dialogue 25 A Clinical Trial for Paralysis Treatment - Epilogue
- Glossary
- Index
How My Cells Became Drugs
How My Cells Became Drugs
- Chapter:
- (p.173) Dialogue 24 How My Cells Became Drugs
- Source:
- Stem Cell Dialogues
- Author(s):
Sheldon Krimsky
- Publisher:
- Columbia University Press
This dialogue is a fictional account of the legal arguments before the U.S. District Court, District of Columbia, regarding the case United States v. Regenerative Sciences LLC. A company named Regenerative Sciences established a clinic in Broomfield, Colorado, to treat patients with a range of orthopedic conditions, including fractures that failed to heal and chronic bursitis, with a stem cell therapy it called RegenexxTM. The therapy consisted of mesenchymal stem cells taken from the patient's bone marrow and grown in tissue culture for about two weeks. The Food and Drug Administration (FDA) warned Regenerative Sciences that its use of stem cell treatments constituted unlicensed biologics and violated federal law. Regenerative Sciences argued that their procedure represented medical practice and lay outside of FDA's jurisdiction. The FDA brought suit against Regenerative Sciences in the United States District Court for the District of Columbia.
Keywords: biologics, United States v. Regenerative Sciences LLC, stem cell therapy, mesenchymal stem cells, bone marrow, Food and Drug Administration
Columbia Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us .
- Title Pages
- Title Pages
- Acknowledgments
- Introduction
- Harnessing Stem Cells for Regenerative Medicine
-
Dialogue 1 Hope -
Dialogue 2 Why is this Cell Different from Other Cells? -
Dialogue 3 The President’s Stem Cells -
Dialogue 4 The Dickey-Wicker Enigma -
Dialogue 5 The Moral Status of Embryos -
Dialogue 6 Creating Good from Immoral Acts -
Dialogue 7 Circumventing Embryocide -
Dialogue 8 My Personalized Beta Cells for Diabetes -
Dialogue 9 Repairing Brain Cells in Stroke Victims -
Dialogue 10 Reversing Macular Degeneration -
Dialogue 11 My Stem Cells, My Cancer -
Dialogue 12 Reprogramming Cells -
Dialogue 13 My Personalized Disease Cells -
Dialogue 14 To Clone or not to Clone -
Dialogue 15 Patenting Human Embryonic Stem Cells is Immoral and Illegal (In Europe) -
Dialogue 16 My Embryo is Auctioned on the Internet -
Dialogue 17 Here Comes the Egg Man -
Dialogue 18 Human-Animal Chimeras and Hybrids -
Dialogue 19 Stem Cell Tourism -
Dialogue 20 Social Media Meet Science Hype -
Dialogue 21 Feminism and the Commercialization of Human Eggs/Embryos -
Dialogue 22 Was My Birth Embryo Me? -
Dialogue 23 Embryos without Ovaries -
Dialogue 24 How My Cells Became Drugs -
Dialogue 25 A Clinical Trial for Paralysis Treatment - Epilogue
- Glossary
- Index